2018 Annual Meeting | C28 - Autism Spectrum Disorders What We Know and Where We Are Going

Date Sunday 04/22/18

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Rujuta B. Wilson, MD

Topic(s)

Learning Objectives Participants should be able to better understand the accurate diagnosis of Autism Spectrum Disorder (ASD), diagnosis and treatment of common medical co-morbidities of ASD, recent clinical trials in ASD and application of new treatments to clinical care, and better understand genetic testing and interpretation in ASD, as well as advances in the neurobiology of ASD. In addition, participants will receive an update on breakthroughs in the field.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Event Timeline
07:00 AM - 07:05 AM	Luncheon	Introduction Rujuta B. Wilson, MD
07:05 AM - 07:40 AM	Speaker	Overview and Updates on the Diagnosis and Treatment of Autism Spectrum Disorder (ASD) and Common Medical Comorbidities in ASD Rujuta B. Wilson, MD
07:40 AM - 07:45 AM	Q&A	Questions and Answers Rujuta B. Wilson, MD
07:45 AM - 08:20 AM	Speaker	Genetic Testing and Interpretation in ASD and Recent Research Advances in the Neurobiology of ASD Julian Martinez Agosto, MD, PhD
08:20 AM - 08:25 AM	Q&A	Questions and Answers Julian Martinez Agosto, MD, PhD
08:25 AM - 08:55 AM	Speaker	Clinical Trials in Autism Spectrum Disorder: Successes and Failures of New Treatments Shafali Jeste, MD, FAAN
08:55 AM - 09:00 AM	Q&A	Questions and Answers Shafali Jeste, MD, FAAN

Faculty Disclosures
Rujuta B. Wilson, MD	Dr. Wilson has nothing to disclose.
Shafali Jeste, MD, FAAN	Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Julian Martinez Agosto, MD, PhD	Julian Martinez Agosto, MD, PhD has nothing to disclose.

��ɫ��

��ɫ��